Global Connectivity
Synexus is the world's leading SMO.
Why? Because we have a global reach, with 31 Dedicated Research Sites
(DRS) across four continents. Yet we deliver rigorous consistency across each
and every site.
Currently we operate centres in 11 countries but all adopt the same model,
quality standards and operating procedures, with local nuances taken into
account. And at every site, our unmatched recruitment and retention
methods ensure patients are fully engaged in clinical trials, which enhances
operational efficiency and research quality. We can also increase our incountry capacity through our key Affiliated Sites (AS).
All of this empowers Synexus to deliver more patients from fewer sites for
global studies in selected therapeutic areas. And all from one point of contact
with Synexus rather than multiple sites.
Radosław Janiak
President and COO
Employee Handbook SA
Version 6 - February 2018